This trial will compare a mobile health platform that uses artificial intelligence and natural language processing (a 'chatbot') to usual care in order to determine if the chatbot system can improve rates of recommendation for genetic testing among patients at elevated risk of familial cancer syndrome in an all-Medicaid gynecology clinic.
1 Primary · 3 Secondary · Reporting Duration: 2 years
150 Total Participants · 2 Treatment Groups
Primary Treatment: Chatbot · No Placebo Group · N/A
Age 18+ · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: